or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    FUSN A Fusion Pharmaceuticals Inc. 0.23
    HALO B Halozyme Therapeutics, Inc. -1.50
    TCRX B TScan Therapeutics, Inc. 0.90
    KURA C Kura Oncology, Inc. -3.52
    LGND C Ligand Pharmaceuticals Incorporated 1.22
    AVBP C ArriVent BioPharma, Inc. -0.25
    SLS C SELLAS Life Sciences Group, Inc. -0.68
    PSTX C Poseida Therapeutics, Inc. -4.63
    LYEL C Lyell Immunopharma, Inc. -1.44
    ONCT C Oncternal Therapeutics, Inc. -1.87
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Life Sciences Cancer Treatment Antibodies Antineoplastic Drugs Cell Biology Chemical Compounds Clinical Development Clinical Medicine Clinical Trial Product Hematologic Malignancies Immune System Insulin Leukemia Lymphoma Medicine Non Small Cell Lung Cancer Oncology

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    GNOM D Global X Genomics & Biotechnology ETF 3.66
    IDNA B iShares Genomics Immunology and Healthcare ETF 2.3
    LABD F Direxion Daily S&P Biotech Bear 3X Shares 1.86
    SBIO C ALPS Medical Breakthroughs ETF 1.78
    XBI C SPDR S&P Biotech ETF 1.59
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare GNOM to SBIO Compare GNOM to XBI Compare IDNA to LABD

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 17 LGND Ionis, Biogen Down on Ending Development of ALS Drug
        May 16 AVBP ArriVent Appoints John Hohneker, M.D., to its Board of Directors
        May 16 HALO Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
        May 16 LGND Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
        May 16 LGND Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
        May 16 HALO Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
        May 16 LGND Insider Sale: President & Chief Operating Officer Matthew Korenberg Sells Shares of Ligand ...
        May 15 LGND FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
        May 14 PSTX Poseida Therapeutics GAAP EPS of -$0.25, revenue of $28.14M
        May 14 SLS SELLAS Life Sciences GAAP EPS of -$0.21
        May 14 PSTX Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
        May 14 SLS SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 14 LGND Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
        May 14 LGND Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
        May 14 LGND Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
        May 14 LGND Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
        May 14 KURA Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
        May 14 TCRX TScan Therapeutics First Quarter 2024 Earnings: Misses Expectations
        May 13 LGND Ligand (LGND) Moves to Strong Buy: Rationale Behind the Upgrade
        May 13 LGND Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Biotechnology Cancer Immune System Cancer Immunotherapy Life Sciences Medicine Clinical Medicine Immunology Immunotherapy Acute Myeloid Leukemia Antibodies Antibody Autoimmune Disease Biology Biopharmaceutical Breast Cancer Cell Therapy Inflammatory Lymphoma Treatment Of Cancer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags